As of 2026-06-10, the EV/EBITDA ratio of Venus Remedies Ltd (VENUSREM.NS) is 10.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VENUSREM.NS's latest enterprise value is 12,992.69 mil INR. VENUSREM.NS's TTM EBITDA according to its financial statements is 1,261.09 mil INR. Dividing these 2 quantities gives us the above VENUSREM.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 9.8x - 10.9x | 10.3x |
| Forward P/E multiples | 9.0x - 10.2x | 9.4x |
| Fair Price | 1,091.35 - 1,702.09 | 1,374.79 |
| Upside | -32.2% - 5.7% | -14.6% |
| Date | EV/EBITDA |
| 2026-06-09 | 10.30 |
| 2026-06-08 | 10.53 |
| 2026-06-05 | 10.45 |
| 2026-06-04 | 9.94 |
| 2026-06-03 | 9.46 |
| 2026-06-02 | 9.00 |
| 2026-06-01 | 8.56 |
| 2026-05-29 | 8.14 |
| 2026-05-27 | 7.74 |
| 2026-05-26 | 7.36 |
| 2026-05-25 | 7.20 |
| 2026-05-22 | 6.85 |
| 2026-05-21 | 6.48 |
| 2026-05-20 | 6.60 |
| 2026-05-19 | 6.35 |
| 2026-05-18 | 6.03 |
| 2026-05-15 | 5.72 |
| 2026-05-14 | 5.92 |
| 2026-05-13 | 5.85 |
| 2026-05-12 | 5.84 |
| 2026-05-11 | 6.09 |
| 2026-05-08 | 6.42 |
| 2026-05-07 | 6.11 |
| 2026-05-06 | 5.87 |
| 2026-05-05 | 6.00 |
| 2026-05-04 | 6.30 |
| 2026-04-30 | 6.09 |
| 2026-04-29 | 5.86 |
| 2026-04-28 | 5.76 |
| 2026-04-27 | 5.90 |
| 2026-04-24 | 5.98 |
| 2026-04-23 | 6.31 |
| 2026-04-22 | 6.66 |
| 2026-04-21 | 6.48 |
| 2026-04-20 | 6.46 |
| 2026-04-17 | 6.55 |
| 2026-04-16 | 6.57 |
| 2026-04-15 | 6.72 |
| 2026-04-13 | 6.56 |
| 2026-04-10 | 6.27 |
| 2026-04-09 | 6.10 |
| 2026-04-08 | 6.06 |
| 2026-04-07 | 5.76 |
| 2026-04-06 | 5.82 |
| 2026-04-02 | 5.68 |
| 2026-04-01 | 5.40 |
| 2026-03-30 | 5.13 |
| 2026-03-27 | 5.36 |
| 2026-03-25 | 5.48 |
| 2026-03-24 | 5.44 |